High-dose midazolam infusion for refractory status epilepticus
Fernandez A, Lantigua H, Lesch C, Shao B, Foreman B, Schmidt JM, Hirsch LJ, Mayer SA, Claassen J. High-dose midazolam infusion for refractory status epilepticus. Neurology 2013, 82: 359-365. PMID: 24363133, PMCID: PMC3929199, DOI: 10.1212/wnl.0000000000000054.Peer-Reviewed Original ResearchConceptsHigh-dose groupRefractory status epilepticusLow-dose groupStatus epilepticusLower mortalityHigh-dose midazolam infusionLower seizure ratesStatus epilepticus onsetClass III evidenceLow-dose protocolHigher infusion ratesHospital complicationsHospital courseSeizure recurrenceBaseline characteristicsSeizure controlWithdrawal seizuresMedian timeDischarge mortalityMidazolam dosesMidazolam infusionSeizure rateWorse outcomesTreatment protocolInfusion rateStatus Epilepticus
Hirsch LJ, Gaspard N. Status Epilepticus. CONTINUUM Lifelong Learning In Neurology 2013, 19: 767-794. PMID: 23739110, PMCID: PMC10564021, DOI: 10.1212/01.con.0000431395.16229.5a.Peer-Reviewed Original ResearchConceptsStatus epilepticusRapid Anticonvulsant MedicationRefractory status epilepticusNeurocritical Care SocietyArrival TrialAnticonvulsant medicationMedical complicationsNonconvulsive seizuresTreatment protocolEpilepticusCurrent evidenceAnesthetic drugsAvailable guidelinesRapid treatmentSuccessful managementEarly considerationTreatmentDiagnosisRecent findingsGuidelinesMedicationsComplicationsOvertreatmentSeizuresManagement